Curasight A/S
CURAS | SPGR
Overview
Corporate Details
- ISIN(s):
- DK0061295797 (+3 more)
- LEI:
- 984500C9E3ADR98F1070
- Country:
- Denmark
- Address:
- Ole Maaløes Vej 3, 2200 København N
- Website:
- https://www.curasight.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Curasight A/S is a clinical-stage biotechnology company developing improved diagnostic and therapeutic solutions for various cancer indications, with a focus on brain and prostate cancer. The company's core technology is its proprietary uPAR Theranostics platform, which combines precise diagnostics (uTRACE®) with targeted radiation therapy (uTREAT®). This integrated approach aims to provide more gentle and efficient cancer care by minimizing radiation exposure to healthy tissue. Based on over a decade of research, Curasight's technology is currently being advanced through several phase II clinical trials.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Curasight A/S.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Curasight A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Curasight A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
